Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-24 @ 6:03 AM
Study NCT ID:
NCT05172466
Status:
WITHDRAWN
Last Update Posted:
2022-11-25
First Post:
2021-11-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsing-remitting Multiple Sclerosis (RRMS) | View |